Molnupiravir CAS 2349386-89-4

Khoom Qhia:

Cov Khoom Npe: Molnupiravir CAS TSIS: 2349386-89-4

Txhais:

EIDD-2801;

((2R, 3S, 4R, 5R) -3,4-Dihydroxy-5- (4- (hydroxyamino) -2-oxopyrimidin-1 (2H) -yl) tetrahydrofuran-2-yl) methyl isobutyrate;

Tshuaj& Cov Khoom Uas Lub Cev:

Zog: Off-dawb rau cov hmoov dawb dawb

Ntsuas: ≥99.0%

Poob rau ziab drying0.5%

Qhov qub ntawm kev tiv thaiv ≤0.1%

ib leeg tsis muaj zog ≤0.2%

ib leeg tsis muaj zog ≤1.0%

Molnupiravir (EIDD-2801) yog cov lus hais ntawm bioavailable ua rau muaj cov kab mob siab heev uas tiv thaiv kev rov ua dua ntawm ntau yam kab mob RNA nrog rau SARS-CoV-2, tus neeg sawv cev ntawm lub koom haum QHID-19. EIDD-2801 tau pom tias ua kom lub ntsws muaj nuj nqi, ua kom lub cev poob qis thiab txo cov kab mob hauv lub ntsws. Ntxiv rau kev ua si tiv thaiv tus kabmob coronaviruses, EIDD-2801, hauv kev kawm tshawb pom, tau ua yam haujlwm tiv thaiv kabmob raws caij nyoog thiab tus kabmob npaws, kabmob ua pa ntawm tus kabmob, kab mob chikungunya, tus kabmob Ebola, tus kabmob Venezuelan equine encephalitis, thiab tus kabmob Eastern equine encephalitis. EIDD-2801 yog cov khoom txhawb nqa ntawm EIDD-1931.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam hauv qab patent yog muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tau txiav txim siab nrog cov neeg yuav khoom.

Cim npe nrov: molnupiravir cas 2349386-89-4, tuam ntxhab, lwm tus neeg, Hoobkas, yuav, hauv Tshuag

• Tug: Methyl-D3-amine Hydrochloride CAS 7436-22-8
• Tom ntej: Ethyl 2,4-dimethyl-1H-pyrrole -3-carboxylate CAS 2199-51-1